Cerevel Therapeutics (CERE) Competitors

CNX Resources (NYSE:CNX) and Cerevel Therapeutics (NASDAQ:CERE) are both mid-cap oils/energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, community ranking, analyst recommendations and dividends.

Does the media favor CNX or CERE?

In the previous week, Cerevel Therapeutics had 5 more articles in the media than CNX Resources. MarketBeat recorded 8 mentions for Cerevel Therapeutics and 3 mentions for CNX Resources. Cerevel Therapeutics' average media sentiment score of 0.60 beat CNX Resources' score of 0.49 indicating that CNX Resources is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CNX Resources	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cerevel Therapeutics	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals hold more shares of CNX or CERE?

95.2% of CNX Resources shares are held by institutional investors. Comparatively, 87.7% of Cerevel Therapeutics shares are held by institutional investors. 3.1% of CNX Resources shares are held by company insiders. Comparatively, 5.1% of Cerevel Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has higher earnings and valuation, CNX or CERE?

CNX Resources has higher revenue and earnings than Cerevel Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CNX Resources	$1.37B	2.94	$1.72B	$5.52	4.76
Cerevel Therapeutics	N/A	N/A	-$432.84M	N/A	N/A

Which has more volatility & risk, CNX or CERE?

CNX Resources has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, Cerevel Therapeutics has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.

Does the MarketBeat Community prefer CNX or CERE?

CNX Resources received 661 more outperform votes than Cerevel Therapeutics when rated by MarketBeat users. Likewise, 70.59% of users gave CNX Resources an outperform vote while only 66.52% of users gave Cerevel Therapeutics an outperform vote.

Company	Underperform	Outperform
CNX Resources	Outperform Votes 816 70.59%	Underperform Votes 340 29.41%
Cerevel Therapeutics	Outperform Votes 155 66.52%	Underperform Votes 78 33.48%

Is CNX or CERE more profitable?

CNX Resources has a net margin of 40.44% compared to CNX Resources' net margin of 0.00%. Cerevel Therapeutics' return on equity of 7.68% beat CNX Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CNX Resources	40.44%	7.68%	3.72%
Cerevel Therapeutics	N/A	-98.94%	-45.07%

Do analysts rate CNX or CERE?

CNX Resources presently has a consensus target price of $25.00, suggesting a potential downside of 4.94%. Cerevel Therapeutics has a consensus target price of $42.67, suggesting a potential upside of 4.73%. Given CNX Resources' stronger consensus rating and higher possible upside, analysts clearly believe Cerevel Therapeutics is more favorable than CNX Resources.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CNX Resources	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cerevel Therapeutics	0 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.11

Summary

CNX Resources beats Cerevel Therapeutics on 9 of the 14 factors compared between the two stocks.